Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
ARRAY BIOPHARMA INC (ARRY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/26/2021 |
GN
| Array Technologies Secures Contract for up to 4GW of Trackers |
| 03/23/2021 |
GN
| Array Technologies, Inc. Announces Closing of Secondary Offering of 35,475,457 Shares |
| 03/18/2021 |
GN
| Array Technologies, Inc. Announces Pricing of Secondary Offering of 31,054,971 Shares |
| 03/16/2021 |
GN
| Array Technologies, Inc. Announces Launch of Secondary Offering of 31,054,971 Shares |
| 03/09/2021 |
GN
| Array Technologies, Inc. Reports Financial Results for the Fourth Quarter and Full Year 2020 |
| 02/19/2021 |
GN
| Array Technologies, Inc. Announces Fourth Quarter & Full-Year 2020 Earnings Release Date and Conference Call |
| 12/07/2020 |
GN
| Array Technologies, Inc. Announces Closing of Secondary Offering of 36,656,250 Shares |
| 12/03/2020 |
GN
| Array Technologies, Inc. Announces Pricing of Upsized Secondary Offering of 31,875,000 Shares |
| 11/30/2020 |
GN
| Array Technologies, Inc. Announces Launch of Secondary Offering of 25 Million Shares |
| 11/30/2020 |
GN
| UPDATE -- Array Technologies announces a 1GW purchase agreement with RP Construction Services |
| 11/10/2020 |
GN
| Lightsource bp announces a 1.4GW global purchase agreement with Array Technologies |
| 10/30/2020 |
GN
| Array Technologies, Inc. Announces Third Quarter 2020 Earnings Release Date and Conference Call |
| 10/19/2020 |
GN
| Array Technologies, Inc. Announces Closing of Initial Public Offering |
| 10/14/2020 |
GN
| Array Technologies, Inc. Announces Pricing of Upsized Initial Public Offering |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/12/2019 |
SC 13G/A
| FMR LLC reports a 0.1% stake in ARRAY BIOPHARMA INC ? |
| 08/09/2019 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 07/30/2019 |
4
| VAN LUNSEN GIL J (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 24,297 shares
@ $48, valued at
$1.2M
Disposed/sold 5,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 259,891 shares
@ $48, valued at
$12.5M
Disposed/sold 442,190 shares
@ $0
Disposed/sold 545,820 options to buy
@ $3.61, valued at
$2M
Disposed/sold 345,312 options to buy
@ $4.63, valued at
$1.6M
Disposed/sold 113,438 options to buy
@ $7.3, valued at
$828.1k
Disposed/sold 453,750 options to buy
@ $3, valued at
$1.4M
Disposed/sold 421,875 options to buy
@ $8.79, valued at
$3.7M
Disposed/sold 600,000 options to buy
@ $10.92, valued at
$6.6M
Disposed/sold 678,750 options to buy
@ $15.97, valued at
$10.8M
|
|
| 07/30/2019 |
4
| Sharp Shalini (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 5,000 shares
@ $48, valued at
$240k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $8.7, valued at
$217.5k
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 209,543 shares
@ $48, valued at
$10.1M
Disposed/sold 114,821 shares
@ $0
Disposed/sold 87,500 options to buy
@ $7.3, valued at
$638.8k
Disposed/sold 187,500 options to buy
@ $3, valued at
$562.5k
Disposed/sold 270,828 options to buy
@ $8.79, valued at
$2.4M
Disposed/sold 289,500 options to buy
@ $10.92, valued at
$3.2M
Disposed/sold 289,500 options to buy
@ $15.97, valued at
$4.6M
|
|
| 07/30/2019 |
4
| Saccomano Nicholas A (CSO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 150,190 shares
@ $48, valued at
$7.2M
Disposed/sold 61,813 shares
@ $0
Disposed/sold 165,000 options to buy
@ $7.3, valued at
$1.2M
Disposed/sold 82,500 options to buy
@ $3, valued at
$247.5k
Disposed/sold 131,250 options to buy
@ $8.79, valued at
$1.2M
Disposed/sold 168,000 options to buy
@ $10.92, valued at
$1.8M
Disposed/sold 138,000 options to buy
@ $15.97, valued at
$2.2M
|
|
| 07/30/2019 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 71,022 shares
@ $48, valued at
$3.4M
Disposed/sold 130,542 shares
@ $0
Disposed/sold 12,500 options to buy
@ $8.2, valued at
$102.5k
Disposed/sold 236,250 options to buy
@ $7.3, valued at
$1.7M
Disposed/sold 236,250 options to buy
@ $3, valued at
$708.8k
Disposed/sold 313,989 options to buy
@ $8.79, valued at
$2.8M
Disposed/sold 335,250 options to buy
@ $10.92, valued at
$3.7M
Disposed/sold 315,750 options to buy
@ $15.97, valued at
$5M
|
|
| 07/30/2019 |
4
| Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 15,000 shares
@ $48, valued at
$720k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 20,000 options to buy
@ $4.51, valued at
$90.2k
Disposed/sold 25,000 options to buy
@ $5.6, valued at
$140k
Disposed/sold 25,000 options to buy
@ $3.87, valued at
$96.8k
Disposed/sold 25,000 options to buy
@ $5.13, valued at
$128.3k
Disposed/sold 25,000 options to buy
@ $5.95, valued at
$148.8k
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| LEFKOFF KYLE (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Unknown transaction of 22,635 shares
@ $48, valued at
$1.1M
Disposed/sold 85 shares
@ $48, valued at
$4.1k
Disposed/sold 5,000 shares
@ $0
Unknown transaction of 20,000 shares
@ $48, valued at
$960k
Unknown transaction of 15,000 shares
@ $48, valued at
$720k
Disposed/sold 30,000 shares
@ $48, valued at
$1.4M
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| Haddock Jason (CFO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 30,059 shares
@ $48, valued at
$1.4M
Disposed/sold 56,026 shares
@ $0
Disposed/sold 404,450 options to buy
@ $3.77, valued at
$1.5M
Disposed/sold 105,302 options to buy
@ $8.79, valued at
$925.6k
Disposed/sold 168,000 options to buy
@ $10.92, valued at
$1.8M
Disposed/sold 157,500 options to buy
@ $15.97, valued at
$2.5M
|
|
| 07/30/2019 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 15,000 shares
@ $48, valued at
$720k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 20,000 options to buy
@ $2.6, valued at
$52k
Disposed/sold 20,000 options to buy
@ $4.36, valued at
$87.2k
Disposed/sold 25,000 options to buy
@ $5.6, valued at
$140k
Disposed/sold 25,000 options to buy
@ $3.87, valued at
$96.8k
Disposed/sold 25,000 options to buy
@ $5.13, valued at
$128.3k
Disposed/sold 25,000 options to buy
@ $5.95, valued at
$148.8k
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| COX CARRIE SMITH (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 8,000 shares
@ $48, valued at
$384k
Disposed/sold 10,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $14.93, valued at
$373.3k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Unknown transaction of 15,000 shares
@ $48, valued at
$720k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 07/30/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/30/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/30/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 07/30/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|
|
|